Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fadi S Farhat, Joseph Kattan & Marwan G Ghosn. (2010) Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer. Expert Review of Anticancer Therapy 10:4, pages 541-548.
Read now
Read now
Articles from other publishers (20)
Andaç KARADENİZ, Mehmet BİLİCİ & Melih ŞİMŞEK. (2022) The effect of demographic features on survival in patients with gastric cancerMide kanserli hastaların demografik özelliklerinin sağ kalıma etkisi. Ege Tıp Dergisi 61:2, pages 166-172.
Crossref
Crossref
C. de la Fouchardiere, L. Decoster, E. Samalin, C. Terret, C. Kenis, J.P. Droz, C. Coutzac & E. Smyth. (2021) Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treatment Reviews 100, pages 102289.
Crossref
Crossref
Davide Zenoni, Flavio Niccolò Beretta, Vanessa Martinelli, Alessandro Iaculli, Maria Teresa Benzoni Fratelli & Delia Bonzi. (2020) Aortic dissection after ramucirumab infusion. European Journal of Hospital Pharmacy 27:2, pages 117-120.
Crossref
Crossref
O. A. Koroleva, L. M. Kogoniya, M. M. Byakhova & A. G. Titov. (2018) CHEMOTHERAPY IN ELDERLY PATIENTS WITH STOMACH CANCER. Malignant tumours 8:2, pages 64-75.
Crossref
Crossref
Rebecca A. Previs, Guillermo N. Armaiz-Pena, Yvonne G. Lin, Ashley N. Davis, Sunila Pradeep, Heather J. Dalton, Jean M. Hansen, William M. Merritt, Alpa M. Nick, Robert R. Langley, Robert L. Coleman & Anil K. Sood. (2015) Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. Molecular Cancer Therapeutics 14:12, pages 2677-2686.
Crossref
Crossref
Roberto Petrioli, Edoardo Francini, Franco Roviello, Daniele Marrelli, Salvatora Tindara Miano, Anna Ida Fiaschi, Letizia Laera, Marco Antonio Bellini & Giandomenico Roviello. (2015) Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥75years with impaired performance status. Journal of Geriatric Oncology 6:5, pages 380-386.
Crossref
Crossref
Mi-Jung KimSook Ryun Park. (2014) Chemotherapy for Advanced Gastric Cancer in Elderly Patients. Korean Journal of Medicine 87:5, pages 521.
Crossref
Crossref
Vincenzo Catalano, Renato Bisonni, Francesco Graziano, Paolo Giordani, Paolo Alessandroni, Anna Maria Baldelli, Virginia Casadei, David Rossi, Stefano Luzi Fedeli, Silvia D’Emidio, Lucio Giustini & Giammaria Fiorentini. (2012) A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer 16:3, pages 411-419.
Crossref
Crossref
Sun Joo Lee, Sukhen C. Ghosh, Hee Dong Han, Rebecca L. Stone, Justin Bottsford-Miller, De Yue Shen, Edmond J. Auzenne, Alejandro Lopez-Araujo, Chunhua Lu, Masato Nishimura, Chad V. Pecot, Behrouz Zand, Duangmani Thanapprapasr, Nicholas B Jennings, Yu Kang, Jie Huang, Wei Hu, Jim Klostergaard & Anil K. Sood. (2012) Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma. Clinical Cancer Research 18:15, pages 4114-4121.
Crossref
Crossref
Hui-yan Luo, Zhi-qiang Wang, Feng-hua Wang, Miao-zhen Qiu, Kai-yuan Teng, Dan-yun Ruan, You-jian He, Yu-hong Li & Rui-hua Xu. (2011) Phase 2 Study of Capecitabine and Irinotecan Combination Chemotherapy (Modified XELIRI Regimen) in Patients With Advanced Gastric Cancer. American Journal of Clinical Oncology 34:6, pages 555-560.
Crossref
Crossref
Sung Rok Kim, Young Jin Yuh, Byeong Seok Sohn & Sung Hyun Yang. (2018) A Phase II Trial of 5-Fluorouracil, Leucovorin and Mitomycin C in Patients with Advanced Gastric Cancer. Tumori Journal 97:6, pages 698-703.
Crossref
Crossref
X.-L. Zhang, H.-J. Shi, S.-Z. Cui, Y.-Q. Tang & M.-C. Ba. (2011) Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma. European Journal of Surgical Oncology (EJSO) 37:6, pages 466-472.
Crossref
Crossref
Daniel Albo, Daniel A. Anaya & David H. Berger. 2011. Principles and Practice of Geriatric Surgery. Principles and Practice of Geriatric Surgery
781
792
.
Anna Dorothea Wagner & Ulrich Wedding. (2009) Advances in the Pharmacological Treatment of Gastro-Oesophageal Cancer. Drugs & Aging 26:8, pages 627-646.
Crossref
Crossref
Nadine A. Jackson, José Barrueco, Raoudha Soufi‐Mahjoubi, John Marshall, Edith Mitchell, Xiaoxi Zhang & Jeffrey Meyerhardt. (2009) Comparing safety and efficacy of first‐line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer. Cancer 115:12, pages 2617-2629.
Crossref
Crossref
Jian Guo Zhao, Feng Qiu, Jian Ping Xiong, Ling Zhang, Xiao Jun Xiang, Feng Yu, Jun Yan, Zhen Yu Zhan & Miao Feng. (2009) A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer. Anti-Cancer Drugs 20:4, pages 281-286.
Crossref
Crossref
Zhi-Fang Liu, Qi-Sen Guo, Xi-Qin Zhang, Xi-Gui Yang, Fang Guan, Zheng Fu & Ming-Yu Wang. (2008) Biweekly Oxaliplatin in Combination With Continuous Infusional 5-Fluorouracil and Leucovorin (Modified FOLFOX-4 Regimen) as First-Line Chemotherapy for Elderly Patients With Advanced Gastric Cancer. American Journal of Clinical Oncology 31:3, pages 259-263.
Crossref
Crossref
Salah-Eddin Al-BatranJoerg Thomas HartmannStephan ProbstHarald SchmalenbergStephan HollerbachRalf HofheinzVolker RethwischGernot SeipeltNils HomannGerhard WilhelmGunter SchuchJan StoehlmacherHans Günter DerigsSusanna Hegewisch-BeckerJohannes GrossmannClaudia PauligkAkin AtmacaCarsten BokemeyerAlexander KnuthElke Jäger. (2008) Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology 26:9, pages 1435-1442.
Crossref
Crossref
Xin-Zu Chen, Kun Jiang, Jian-Kun Hu, Bo Zhang, Hong-Feng Gou, Kun Yang, Zhi-Xin Chen & Jia-Ping Chen. (2008) Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World Journal of Gastroenterology 14:17, pages 2715.
Crossref
Crossref
S C Oh, H Y Sur, H J Sung, I K Choi, S S Park, J H Seo, Y T Jeen, H J Chun, S W Shin, Y J Mok, J S Kim & Y H Kim. (2007) A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. British Journal of Cancer 96:10, pages 1514-1519.
Crossref
Crossref